Optical Coherence Tomography of Airway and Pleural Disorders

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Montana Compton, University of California, Irvine
ClinicalTrials.gov Identifier:
NCT00580892
First received: December 20, 2007
Last updated: December 26, 2012
Last verified: December 2012

December 20, 2007
December 26, 2012
July 2007
July 2015   (final data collection date for primary outcome measure)
Screening aid in identification of suspect tissue lesion. [ Time Frame: 30 MINUTES ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00580892 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Optical Coherence Tomography of Airway and Pleural Disorders
Optical Coherence Tomography of Airway and Pleural Disorders

Endobronchial disorders represent abnormal processes within the network of passages delivering air to the lung, including lung cancers. Pleural disorders involve the membrane that covers the lung and lines the inside of the chest walls.

Early detection of these disorders is essential to timely, accurate diagnosis and treatment of these conditions including cancer, inflammation and infections.

Optical methods for obtaining images in airway passages for early detection of endobronchial lung and pleural cancer are needed. Optical coherence tomography (OCT) is a non-invasive or minimally invasive diagnostic technique that can provide information about tissue abnormalities.

OCT can produce images of abnormalities both at and below the surface of the airways without damaging the tissue surface This technique uses a harmless device to emit infrared (not visible) light that can produce images of the specimen under investigation without causing damage or alterations.

Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

primary care clinic

Endobronchial Disorder
Device: OCT
imaging
diagnostic
imaging
Intervention: Device: OCT
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Enrolling by invitation
150
July 2015
July 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • adult 18 or older, male or female.
  • require bronchoscopic with possible biopsy procedures.

Exclusion Criteria:

  • age less than 18 years of age
  • NO bronchoscopic with possible biopsy procedures.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00580892
NIH OCT. EB-093-07
No
Montana Compton, University of California, Irvine
Montana Compton
Not Provided
Principal Investigator: Matthew Brenner, M.D Beckman Laser Institute
University of California, Irvine
December 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP